Bioethics
All research submitted to the Eurasian Journal of Molecular and Biochemical Sciences for consideration must have been conducted in accordance with Eurasian Journal of Molecular and Biochemical Sciences guidelines on study ethics. In accordance with COPE guidelines, the Eurasian Journal of Molecular and Biochemical Sciences reserves the right to reject any manuscript that editors believe does not uphold high ethical standards, even if authors have obtained ethical approval or if ethical approval is not required. Eurasian Journal of Molecular and Medical Sciences encourages authors to follow the ARRIVE guidelines for the design, analysis, and reporting of scientific research.
- Studies Involving Animal Subjects
An approval of research protocols by the Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, and drug studies. If required, ethics committee reports or an equivalent official document will be requested from the authors. For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly. Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript. It is the authors’ responsibility to protect the patients’ anonymity carefully.
All research involving regulated animals (i.e. all live vertebrates and higher invertebrates) must have been reviewed and approved by an ethics committee prior to commencing the study and performed in accordance with relevant institutional and national guidelines and regulations. Eurasian Journal of Molecular and Medical Sciences follows the International Association of Veterinary Editors guidelines for publication of studies including animal research. Clinical studies involving animals and interventions outside of routine care require ethics committee oversight as per the AVMA (Animal Health Studies Database). Authors must provide ethics approval information within the submission system, which generates an ethics statement to be included in the submission file.
Should the study be exempt from ethics approval, authors need to state the reasons for exemption within the generated statement. Studies involving client-owned animals (non-commercially available animals, e.g. pets or livestock) should demonstrate the best practice veterinary care and confirm that written informed consent has been granted by the owner(s), or the legal representative of the owner(s). An example of a generated statement for a study involving client-owned animals can be found below:
“The animal study was reviewed and approved by [Full name and affiliation of ethics committee]. Written informed consent was obtained from the owners for the participation of their animals in this study”.
1.1. Humane Endpoints
All manuscripts describing studies where death is an endpoint will be subject to additional ethical considerations. Eurasian Journal of Molecular and Medical Sciences reserves the right to reject manuscripts lacking appropriate justification.
- Studies Involving Human Subjects
Research involving human subjects should have been conducted in accordance with the World Medical Association’s Declaration of Helsinki. Studies involving human participants must be performed in accordance with relevant institutional and national guidelines, with the appropriate institutional ethics committee's prior approval and informed written consent from all human subjects involved in the study including for publication of the results. Confirmation of this approval is required upon submission of a manuscript to Eurasian Journal of Molecular and Medical Sciences; authors must provide ethics committee information within the submission system, which generates an ethics statement to be included in the submission. Information regarding subjects’ (or when appropriate, the parent’s or guardian’s) consent for participation should be provided within the submission system. Eurasian Journal of Molecular and Medical Sciences requires that consent for participation is both informed and written unless waived by an ethics committee or otherwise not required as per local legislation.
“The studies involving human participants were reviewed and approved by [Full name and affiliation of ethics committee]. The patients/participants provided their written informed consent to participate in this study”.
Should the study be exempt from ethics approval or consent procedures, authors need to clearly state the reasons in the generated statement. Eurasian Journal of Molecular and Medical Sciences may request a letter from the authors, obtained from an ethics committee in cases where full review and approval has been waived by the committee.
In order to protect subject anonymity, identifying information should not be included in the manuscript unless such information is absolutely necessary for scientific purposes AND explicit approval has been granted by the subjects.
